Follow the people · Insider
Eric Weinberg
Eric Weinberg files insider transactions with the SEC as an officer of RxSight (RXST). We hold 1 disclosed purchase or sale filed since 2 May 2006, 1 of them in the last 90 days.
- Files forRXST
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure2 September 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 30 July 2021 — 2 September 2026Officer · RxSight (RXST)24 Form 4 lines · source: SEC Form 4
- Filed 28 April 2006 — 2 April 2007V.P. Mktg & Prof. Affairs · Intralase (ILSE)22 Form 4 lines · source: SEC Form 4
Everything they disclosed
46 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 5,370 shares of RxSightSEC Form 42 September 2026Common Stock · traded 31 August 2026 · filed 2 September 2026
- ▼ sold on the open market 2,041 shares of RxSightSEC Form 42 September 2026Common Stock · traded 2 September 2026 · filed 2 September 2026
- exercised options over 5,370 shares of RxSight (a derivative holding)SEC Form 42 September 2026Restricted Stock Unit · traded 31 August 2026 · filed 2 September 2026
- was granted 32,218 shares of RxSight (a derivative holding)SEC Form 43 March 2026Restricted Stock Unit · traded 27 February 2026 · filed 3 March 2026
- was granted 32,218 shares of RxSight (a derivative holding)SEC Form 43 March 2026Restricted Stock Unit · traded 27 February 2026 · filed 3 March 2026
- exercised options over 188,002 shares of RxSight (a derivative holding)SEC Form 43 June 2025Stock Option (right to buy) · traded 2 June 2025 · filed 3 June 2025
- exercised options over 188,002 shares of RxSightSEC Form 43 June 2025Common Stock · traded 2 June 2025 · filed 3 June 2025
- was granted 125,000 shares of RxSight (a derivative holding)SEC Form 427 February 2025Stock Option (right to buy) · traded 27 February 2025 · filed 27 February 2025
- was granted 50,000 shares of RxSight (a derivative holding)SEC Form 48 August 2024Stock Option (right to buy) · traded 7 August 2024 · filed 8 August 2024
- was granted 92,200 shares of RxSight (a derivative holding)SEC Form 46 March 2024Stock Option (right to buy) · traded 4 March 2024 · filed 6 March 2024
- ▼ sold on the open market 10,000 shares of RxSightSEC Form 42 February 2024Common Stock · traded 1 February 2024 · filed 2 February 2024
- ▼ sold on the open market 10,000 shares of RxSightSEC Form 422 January 2024Common Stock · traded 22 January 2024 · filed 22 January 2024
- ▼ sold on the open market 10,000 shares of RxSightSEC Form 410 January 2024Common Stock · traded 9 January 2024 · filed 10 January 2024
- ▼ sold on the open market 10,000 shares of RxSightSEC Form 49 January 2024Common Stock · traded 8 January 2024 · filed 9 January 2024
- ▼ sold on the open market 1,285 shares of RxSightSEC Form 426 December 2023Common Stock · traded 22 December 2023 · filed 26 December 2023
- ▼ sold on the open market 8,715 shares of RxSightSEC Form 419 December 2023Common Stock · traded 15 December 2023 · filed 19 December 2023
- was granted 95,000 shares of RxSight (a derivative holding)SEC Form 410 March 2023Stock Option (right to buy) · traded 9 March 2023 · filed 10 March 2023
- ▲ bought on the open market 210 shares of RxSightSEC Form 46 August 2021Common Stock · traded 30 July 2021 · filed 6 August 2021
- ▲ bought on the open market 90 shares of RxSightSEC Form 46 August 2021Common Stock · traded 2 August 2021 · filed 6 August 2021
- ▲ bought on the open market 1 share of RxSightSEC Form 46 August 2021Common Stock · traded 3 August 2021 · filed 6 August 2021
- ▲ bought on the open market 615 shares of RxSightSEC Form 46 August 2021Common Stock · traded 4 August 2021 · filed 6 August 2021
- ▲ bought on the open market 9 shares of RxSightSEC Form 46 August 2021Common Stock · traded 5 August 2021 · filed 6 August 2021
- ▲ bought on the open market 31,250 shares of RxSightSEC Form 45 August 2021Common Stock · traded 3 August 2021 · filed 5 August 2021
- was granted 87,437 shares of RxSight (a derivative holding)SEC Form 42 August 2021Stock option (right to buy) · traded 31 July 2021 · filed 2 August 2021
- returned to the issuer 542 shares of Intralase (a derivative holding)SEC Form 44 April 2007Employee Stock Option (right to buy) · traded 2 April 2007 · filed 4 April 2007
- returned to the issuer 901 shares of Intralase (a derivative holding)SEC Form 44 April 2007Employee Stock Option (right to buy) · traded 2 April 2007 · filed 4 April 2007
- returned to the issuer 2,104 shares of Intralase (a derivative holding)SEC Form 44 April 2007Employee Stock Option (right to buy) · traded 2 April 2007 · filed 4 April 2007
- returned to the issuer 5,870 shares of Intralase (a derivative holding)SEC Form 44 April 2007Employee Stock Option (right to buy) · traded 2 April 2007 · filed 4 April 2007
- returned to the issuer 26,630 shares of Intralase (a derivative holding)SEC Form 44 April 2007Employee Stock Option (right to buy) · traded 2 April 2007 · filed 4 April 2007
- returned to the issuer 5,734 shares of Intralase (a derivative holding)SEC Form 44 April 2007Employee Stock Option (right to buy) · traded 2 April 2007 · filed 4 April 2007
- returned to the issuer 19,266 shares of Intralase (a derivative holding)SEC Form 44 April 2007Employee Stock Option (right to buy) · traded 2 April 2007 · filed 4 April 2007
- returned to the issuer 183,200 shares of IntralaseSEC Form 44 April 2007Common Stock · traded 2 April 2007 · filed 4 April 2007
- exercised options over 13,530 shares of Intralase (a derivative holding)SEC Form 430 March 2007Employee Stock Option (right to buy) · traded 28 March 2007 · filed 30 March 2007
- exercised options over 16,400 shares of Intralase (a derivative holding)SEC Form 430 March 2007Employee Stock Option (right to buy) · traded 28 March 2007 · filed 30 March 2007
- exercised options over 50,507 shares of Intralase (a derivative holding)SEC Form 430 March 2007Employee Stock Option (right to buy) · traded 28 March 2007 · filed 30 March 2007
- exercised options over 5,111 shares of Intralase (a derivative holding)SEC Form 430 March 2007Employee Stock Option (right to buy) · traded 28 March 2007 · filed 30 March 2007
- exercised options over 13,530 shares of IntralaseSEC Form 430 March 2007Common Stock · traded 28 March 2007 · filed 30 March 2007
- exercised options over 16,400 shares of IntralaseSEC Form 430 March 2007Common Stock · traded 28 March 2007 · filed 30 March 2007
- exercised options over 50,507 shares of IntralaseSEC Form 430 March 2007Common Stock · traded 28 March 2007 · filed 30 March 2007
- exercised options over 5,111 shares of IntralaseSEC Form 430 March 2007Common Stock · traded 28 March 2007 · filed 30 March 2007
- had shares withheld for tax on 1,376 shares of IntralaseSEC Form 430 March 2007Common Stock · traded 28 March 2007 · filed 30 March 2007
- had shares withheld for tax on 948 shares of IntralaseSEC Form 430 March 2007Common Stock · traded 28 March 2007 · filed 30 March 2007
- had shares withheld for tax on 2,919 shares of IntralaseSEC Form 430 March 2007Common Stock · traded 28 March 2007 · filed 30 March 2007
- had shares withheld for tax on 920 shares of IntralaseSEC Form 430 March 2007Common Stock · traded 28 March 2007 · filed 30 March 2007
- was granted 5,870 shares of Intralase (a derivative holding)SEC Form 42 May 2006Incentive Stock Option (right to buy) · traded 28 April 2006 · filed 2 May 2006
- was granted 26,630 shares of Intralase (a derivative holding)SEC Form 42 May 2006Non-Qualified Stock Option (right to buy) · traded 28 April 2006 · filed 2 May 2006
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.